ClinicalTrials.govpublic full text
A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)
crohn's disease, crohn's disease, cdp870, cdai, clinical response, remission,, certolizumab pegol, cimzia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854494
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.